Published on 21/08/2025 03:54 PM
Piramal Pharma Share Price: Shares of Piramal Pharma Limited rose over 2 per cent following the company’s announcement of a significant investment in its subsidiary, PPL Pharma.
On Thursday, the pharma stock surged as much as 2.32 per cent, reaching an intraday high of Rs 196.25 on the BSE.
The company stated that the total investment amounts to $190.3 million (approximately Rs 1,626.49 crore).
In its first quarter results, Piramal Pharma reported a net loss of Rs 81.7 crore, compared with a net profit of Rs 153.5 crore in the previous quarter. The company had also reported a net loss in the same quarter last year.
Add Zee Business as a Preferred Source
Revenue for the quarter stood at Rs 1,933.71 crore, marking a 1 per cent decline year-on-year and nearly a 30 per cent decline on a sequential basis. Earnings Before Interest, Tax, Depreciation, and Amortisation (EBITDA) fell to Rs 106.7 crore, almost half of the previous year’s figure, and dropped approximately 86 per cent compared to the preceding quarter. Correspondingly, the EBITDA margin decreased to 5.5 per cent from 10.5 per cent in the previous year and 26.9 per cent in the March quarter.
The company’s contract development and manufacturing organisation (CDMO) business revenue declined by 6 per cent year-on-year to Rs 997 crore, impacted by destocking of a large on-patent commercial product.
Despite the challenging quarter, Piramal Pharma said it remains on track to achieve its financial targets for FY 2030, aiming for $2 billion in revenue with a 25 per cent margin.
The pharma stock closed at Rs 192.50 apiece on the NSE, up 0.37 per cent on Thursday, August 21.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
LATEST NEWSBy accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.